Ercros, S.A. (FRA:CRS1)

Germany · Delayed Price · Currency is EUR

3.460

0.00 (0.00%)

Sep 23, 2026, 4:00 PM EDT

Market Cap	319.11M +27.1%
Revenue (ttm)	636.04M -2.9%
Net Income	-28.23M
EPS	-0.31
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	3.460
Previous Close	3.460
Day's Range	3.460 - 3.460
52-Week Range	2.210 - 3.555
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ... [Read more]

Industry Chemicals

Sector Materials

Founded 1817

Employees 1,346

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol CRS1

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.

Financial Statements